KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$10.78 USD
+0.29 (2.76%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.80 +0.02 (0.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/5/24 |
---|---|
Current Quarter | -0.69 |
EPS Last Quarter | -0.84 |
Last EPS Surprise | -12.00% |
ABR | 1.17 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.05 |
Next Year | -2.46 |
EPS (TTM) | -3.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 26.80M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 35.51M |
Low Estimate | NA | NA | NA | 18.09M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.69 | -0.65 | -3.05 | -2.46 |
# of Estimates | 4 | 2 | 5 | 4 |
Most Recent Consensus | -0.55 | -0.72 | -2.84 | -2.83 |
High Estimate | -0.55 | -0.57 | -2.84 | -1.71 |
Low Estimate | -0.78 | -0.72 | -3.33 | -3.16 |
Year ago EPS | -0.77 | -0.74 | -3.33 | -3.05 |
Year over Year Growth Est. | 10.39% | 12.16% | 8.41% | 19.43% |
Agreement - Estimate Revisions
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 2 | 0 | 1 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Current | -0.69 | -0.65 | -3.05 | -2.46 |
7 Days Ago | -0.69 | -0.65 | -3.05 | -2.46 |
30 Days Ago | -0.69 | -0.57 | -3.05 | -2.53 |
60 Days Ago | -0.77 | NA | -3.09 | -2.77 |
90 Days Ago | -0.64 | NA | -2.98 | -2.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.69 | -0.72 | -3.05 | -2.83 |
Zacks Consensus Estimate | -0.69 | -0.65 | -3.05 | -2.46 |
Earnings ESP | 0.00% | -11.63% | 0.00% | -15.16% |
Surprise - Reported Earnings History
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Quarter Ending (4/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.84 | -0.80 | -0.74 | -0.77 | NA |
Estimate | -0.75 | -0.71 | -0.83 | -0.92 | NA |
Difference | -0.09 | -0.09 | 0.09 | 0.15 | 0.02 |
Surprise | -12.00% | -12.68% | 10.84% | 16.30% | 0.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more